Sisram Medical will Report H1 2025 Financial Results on August 20 and Hold a Conference Call on August 21

H1 2025 conference call to be held on August 21, at 8:30 a.m. Eastern Time Sisram Medical Ltd(the “Company” or “Sisram”, stock code: 1696.HK; together with its subsidiaries referred to as the “Group”), a global consumer wellness group featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused brands, including energy-based devices, injectables, and […]

GO RESIDENTIAL REAL ESTATE INVESTMENT TRUST ANNOUNCES INITIAL CASH DISTRIBUTION

GO Residential Real Estate Investment Trust (the “REIT”) (TSX: GO.U) today announced a cash distribution of US$0.05325 per trust unit of the REIT (“Unit”) for the period from July 31, 2025 (the closing date of the REIT's initial public offering) to August 31, 2025, representing US$0.639 per Unit on an annual basis. Payment will be

MEDIA ALERT – VISIT A&W ON BURGERS TO BEAT MS DAY, AUGUST 21, IN SUPPORT OF MS CANADA

On Thursday, August 21 A&W Canada will donate $2 from every Teen Burger sold to MS Canada A&W Burgers to Beat MS Day is back on Thursday, August 21to support Canadians living with and affected by multiple sclerosis (MS). Since its inception, A&W's Burgers to Beat MS Day has raised more than $21.7 million in

BTB REIT Announces its Distribution for the Month of August 2025

BTB Real Estate Investment Trust (TSX: BTB.UN) (“BTB” or the “REIT”) announced today that the monthly cash distribution for the month of August 2025 is $0.025 per unit, representing $0.30 per unit on an annualized basis. The cash distribution will be paid on September 15th, 2025, to unitholders of record on August 29th, 2025. AboutBTB

SOLOWIN Unveils Real Yield Token (RYT), Targeting US$1 Billion AUM

SOLOWIN Unveils Real Yield Token (RYT), Targeting US$1 Billion AUM GlobeNewswire August 14, 2025 Collaborate with Polygon, Arbitrum and Solana to deliver scalable blockchain infrastructure for regulated tokenized yield product HONG KONG, Aug. 14, 2025 (GLOBE NEWSWIRE) — SOLOWIN HOLDINGS (NASDAQ: SWIN) (“Solowin” or the “Company”), a leading financial services firm providing comprehensive solutions across

Lifeward Ltd. Reports Second Quarter 2025 Financial Results

Lifeward Ltd. Reports Second Quarter 2025 Financial Results GlobeNewswire August 14, 2025 Achieves record number of ReWalk systems placed for Medicare beneficiaries since fee schedule established Third consecutive quarter of U.S. ReWalk pipeline growth with over 130 qualified leads in process Appoints new CEO and CFO to spearhead strategic change and accelerate growth MARLBOROUGH, Mass.

TTM Technologies, Inc. Appoints Edwin Roks, Ph.D. as President and Chief Executive Officer and Member of Board of Directors

TTM Technologies, Inc. Appoints Edwin Roks, Ph.D. as President and Chief Executive Officer and Member of Board of Directors GlobeNewswire August 14, 2025 SANTA ANA, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) — TTM Technologies, Inc. (NASDAQ: TTMI), a leading global manufacturer of technology solutions including mission systems, radio frequency (“RF”) components and RF microwave/microelectronic assemblies,

Cycurion, Inc. Reports Financial Results for the Second Quarter of 2025

Cycurion, Inc. Reports Financial Results for the Second Quarter of 2025 GlobeNewswire August 14, 2025 MCLEAN, Va., Aug. 14, 2025 (GLOBE NEWSWIRE) — Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a premier cybersecurity and IT solutions provider, today announced its financial results for the second quarter and first half of 2025. Amid headwinds from

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results GlobeNewswire August 14, 2025 – Gained alignment with U.S. Food and Drug Administration (FDA) on the ongoing Phase 2 AQUAx2 randomized double-blind, placebo-controlled pivotal study in Grade 2/3 radiation-induced xerostomia (RIX) to support a potential Biologics License Application (BLA) filing; on track for potential data readout

PharmaTher Founder and CEO Issues Letter to Shareholders following the FDA Approval of Ketamine (KETARx(TM))

PharmaTher Founder and CEO Issues Letter to Shareholders following the FDA Approval of Ketamine (KETARx(TM)) GlobeNewswire August 14, 2025 TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, announced today that Fabio Chianelli, the

Scroll to Top